OUTCOMES OF OXALIPLATIN- BASED ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: A RETROSPECTIVE STUDY AT HANOI MEDICAL UNIVERSITY HOSPITAL. YHCĐ. 2026;67(10). doi:10.52163/yhc.v67i10.6925